On April 7, 2026, the European Commission announced a €700 million pledge to the Global Fund’s 8th replenishment for HIV, tuberculosis and malaria, with €185 million immediately available. It also committed €46.5 million to strengthen One Health cooperation between Africa and Europe, targeting antimicrobial resistance (AMR) surveillance, laboratory capacity and cross‑regional collaboration over five years. In addition, €50 million will fund research and development for AMR and neglected tropical diseases: €30 million to support new antibiotics through CARB‑X and GARDP, and €20 million to advance dengue treatments via the Drugs for Neglected Diseases initiative. These measures are part of the Global Health Resilience Initiative launched by the EU.
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.